London-based investment firm Bridgepoint has agreed to purchase RoC Skincare from Gryphon Investors.
Founded by Dr. Jean-Charles Lissarrague in 1957, RoC offers dermatologist-backed skincare solutions with a focus on ageing.
It was previously acquired by Gryphon Investors from Johnson & Johnson and established as an independent business in 2020.
The new deal will support RoC in further accelerating its growth across Europe and will benefit from Bridgepoint’s European presence and expertise in the dermatology sectors.
Fernando Acosta, CEO of RoC Skincare, said: “With Bridgepoint’s deep expertise in the dermatology sector and its strong European presence, RoC is poised to capitalise on the promising growth opportunities that lie ahead.”
Fabrice Turcq, Partner at Bridgepoint, added: “Under Fernando’s leadership, RoC has become an impressive standalone business with a rich European heritage and dermatology expertise.
“The company’s unique, clinically proven products for ageing skin conditions are a highly appealing customer proposition with significant growth opportunities. With Bridgepoint’s support, RoC is poised to accelerate growth in Europe and beyond, strengthen its online presence and expand its product offering.”
The transaction is expected to close in February 2024.
